Increasing the dose of human menopausal gonadotrophins on day of GnRH antagonist administration: randomized controlled trial

This publication has 13 references indexed in Scilit:

• The use of gonadotropin-releasing hormone antagonist in a flexible protocol: a pilot study
  American Journal of Obstetrics and Gynecology, 2003
• Meta-analysis of recombinant versus urinary-derived FSH: an update
  Human Reproduction, 2003
• Reproductive outcome of polycystic ovarian syndrome patients treated with GnRH antagonists and recombinant FSH for IVF/ICSI
  Reproductive BioMedicine Online, 2003
• Tailoring the GnRH antagonist cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF: results of a prospective, randomized study.
  Human Reproduction, 2002
• GnRH antagonist in assisted reproduction: a Cochrane review
  Human Reproduction, 2002
• Gonadotropin-releasing hormone antagonist: how good is the new hope?
  Current Opinion in Obstetrics and Gynecology, 2001
• Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation
  Human Reproduction, 2001
• Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial
  Human Reproduction, 2000
• Embryo implantation and GnRH antagonists
  Human Reproduction, 2000
• Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin
  Human Reproduction, 2000